Sana Biotechnology, Inc. (NASDAQ:SANA) has 198 institutional investors that have filed 13F reports for the period ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Mar, 2026 | 37,430,284 | 0 | 0.00% | $107,799,219.00 |
| Flagship Pioneering, LLC | 31 Mar, 2026 | 25,001,856 | 0 | 0.00% | $72,005,346.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 14,240,175 | 16,648 | 0.12% | $41,011,704.00 |
| State Street Corp | 31 Mar, 2026 | 10,538,086 | 2,483,245 | 30.83% | $30,349,688.00 |
| CANADA PENSION PLAN INVESTMENT BOARD | 31 Mar, 2026 | 10,221,900 | -20,200 | -0.20% | $29,439,072.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 7,434,724 | 7,434,724 | 0.00% | $21,412,005.00 |
| BAILLIE GIFFORD & CO | 31 Mar, 2026 | 6,609,065 | 0 | 0.00% | $19,034,107.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 4,181,973 | 63,835 | 1.55% | $12,046,360.00 |
| Marex Group plc | 31 Mar, 2026 | 3,999,100 | 266,320 | 7.13% | $11,517,408.00 |
| Integral Health Asset Management, LLC | 31 Mar, 2026 | 3,200,000 | 200,000 | 6.67% | $9,216,000.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 3,181,115 | 204,361 | 6.87% | $9,161,611.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 2,946,861 | 1,760,610 | 148.42% | $8,486,960.00 |
| Alphabet Inc. | 31 Mar, 2026 | 2,812,500 | 0 | 0.00% | $8,100,000.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 1,707,521 | 1,707,521 | 0.00% | $4,917,660.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 1,591,030 | 967,788 | 155.28% | $4,582,166.00 |
| Crestline Management, L.P. | 31 Mar, 2026 | 1,511,472 | 290,535 | 23.80% | $4,353,040.00 |
| Northern Trust Corp | 31 Mar, 2026 | 1,478,851 | 71,152 | 5.05% | $4,259,092.00 |
| Morgan Stanley | 31 Mar, 2026 | 1,460,015 | 174,970 | 13.62% | $4,204,843.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 1,451,200 | -239,916 | -14.19% | $4,179,456.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Mar, 2026 | 1,366,148 | -33,187 | -2.37% | $3,934,506.00 |